The World's Greatest Investing Community
Results 21 - 30 of 182 : Previous 1 2 3 4 5 6 7 8 9 Next
Is Alexion Pharmaceuticals the Perfect Stock?
Finding companies that have all the right stuff can produce winners.
4-Star Stocks Poised to Pop: ViroPharma
Market-trouncing returns could be written in these four stars.
Down! Up! Which Way Will Optimer Go Next?
Long-term prospects look good.
Optimer's Upcoming FDA Decision: Memorable or Memorial?
We'll know on Memorial Day, plus or minus a few days.
Testing a subcutaneous form of Cinryze.
Uncontrolled Crying Over AVANIR's Prescription Data?
A slow start, but don't write off the company yet.
ViroPharma Shares Plunged: What You Need to Know
Is this meaningful? Or just another movement?
Killing Bacteria With the Help of a Friend
Optimer enlists the services of Cubist.
Anti-Infective, Very Effective
The FDA seems to like Optimer's new antibiotic.
Why the Street Should Love ViroPharma's Earnings
All cash flow is not created equal.
BATS data provided in real-time. NYSE, NASDAQ and AMEX data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates and Analyst Ratings provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK